Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
- PMID: 28270175
- PMCID: PMC5341450
- DOI: 10.1186/s13063-017-1848-0
Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
Erratum for
-
Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.Trials. 2017 Feb 2;18(1):52. doi: 10.1186/s13063-017-1777-y. Trials. 2017. PMID: 28148280 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
